Astrocytoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Fahimeh Shojaei (talk | contribs)
No edit summary
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 10: Line 10:
! colspan="2" rowspan="4" |Diseases
! colspan="2" rowspan="4" |Diseases
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
! colspan="4" rowspan="2" |Para-clinical findings
! colspan="3" rowspan="2" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
Line 18: Line 18:
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
!Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology
|-  
|-  
Line 29: Line 29:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Focal neurologic deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Focal neurologic deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Endocrine abnormalities/?
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Endocrine abnormalities/?
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
|-
|-
Line 42: Line 41:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Supratentorial
* Supratentorial
Line 80: Line 78:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Almost always in cerebral hemisphers (frontal lobes)
* Almost always in cerebral hemisphers (frontal lobes)
Line 110: Line 107:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Well circumscribed
* Well circumscribed
Line 141: Line 137:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Infratentorial
* Infratentorial
Line 166: Line 161:
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
* Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas
* Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Isointense to normal pituitary gland in T1
* Isointense to normal pituitary gland in T1
Line 189: Line 183:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Split-fat sign
* Split-fat sign
Line 212: Line 205:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Usually deep in the [[white matter]]
* Usually deep in the [[white matter]]
Line 238: Line 230:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Infratentorial
* Infratentorial
Line 264: Line 255:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Infratentorial
* Infratentorial
Line 289: Line 279:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Infratentorial
* Infratentorial
Line 316: Line 305:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hypopituitarism as a result of pressure effect on pituitary gland
* Hypopituitarism as a result of pressure effect on pituitary gland
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Calcification
* Calcification
Line 340: Line 328:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* + B-hCG rise leads to precocious puberty in males
* + B-hCG rise leads to precocious puberty in males
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hydrochepalus (compression of cerebral aqueduct)
* Hydrochepalus (compression of cerebral aqueduct)
Line 359: Line 346:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Bag of worms" appearance in CT angiography
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Supratentorial: ~85%
* Supratentorial: ~85%
Line 369: Line 354:
* Angiography
* Angiography
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* We may see bag of worms" appearance in CT angiography
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain aneurysm
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain aneurysm
Line 379: Line 365:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In CT angiography, we may see aneurysm mostly in anterior circulation (~85%)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In magnetic resonance angiography, we may see aneurysm mostly in anterior circulation (~85%)
* In magnetic resonance angiography, we may see aneurysm mostly in anterior circulation (~85%)
Line 403: Line 387:
* Elevated ESR
* Elevated ESR
* Blood culture may be positive for underlying organism
* Blood culture may be positive for underlying organism
| style="background: #F5F5F5; padding: 5px;" |
* Round area of hypoattenuation
* Ring enhancement
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Central hypodense signal and surrounding ring-enhancement in T1
* Central hypodense signal and surrounding ring-enhancement in T1
Line 425: Line 406:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hydrocephalus combined with marked basilar meningeal enhancement
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 432: Line 413:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxoplasmosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxoplasmosis
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 449: Line 429:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydatid cyst
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydatid cyst
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 466: Line 445:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fungal  
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fungal  
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 482: Line 460:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain metastasis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain metastasis
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 16:02, 21 January 2019

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma differential diagnosis

CDC on Astrocytoma differential diagnosis

Astrocytoma differential diagnosis in the news

Blogs on Astrocytoma differential diagnosis

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Differentiating astrocytoma from other Diseases

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Immunohistopathology
Headache Seizure Visual disturbance Hearing loss Constitutional Extraocular movement disorder Focal neurologic deficit Endocrine abnormalities/? MRI
Adult primary brain tumors Glioblastoma multiforme + +/− +/− +
  • Supratentorial
  • Cross corpus callosum (butterfly glioma)
  • Astrocyte origin
  • Pleomorphic cell
  • Pseudopalisading appearance
  • GFAP +
  • Necrosis +
  • Hemorrhage +
  • Vascular prolifration +
  • Biopsy
  • Highest incidence in fifth and sixth decades of life
  • Most of the time, focal neurological deficit is the presenting sign.
Oligodendroglioma + + +/− +
  • Almost always in cerebral hemisphers (frontal lobes)
  • Chicken wire capillary pattern
  • Oligodendrocyte origin
  • Calcification +
  • Fried egg cell appearance
  • Biopsy
  • Highest incidence is between 40 and 50 years of age.
  • Most of the time, epileptic seizure is the presenting sign.
Meningioma + +/− +/− +
  • Well circumscribed
  • Extra-axial mass
  • Arachnoid origin
  • Psammoma bodies
  • Whorled spindle cell pattern
  • Biopsy
  • Highest incidence is between 40 and 50 years of age.
  • Most of the time, focal neurological deficit and epileptic seizure are the presenting signs.
  • May be associated with NF-2
Hemangioblastoma + +/− +/− +
  • Infratentorial
  • Cystic lesion with a solid enhancing mural nodule
  • Blood vessel origin
  • Capillaries with thin walls
  • Biopsy
Pituitary adenoma + Bitemporal hemianopia
  • Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas
  • Isointense to normal pituitary gland in T1
  • Endocrine cell hyperplasia
  • Biopsy
  • Initialy presents with upper bitemporal quadrantanopsia followed by bitemporal hemianopsia (pressure on optic chiasma from below)
Schwannoma +/− +
  • Split-fat sign
  • Fascicular sign
  • Often have areas of hemosiderin
  • Schwann cell origin
  • S100+
  • Biopsy
  • May be associated with NF-2 (bilateral schwannomas)
Primary CNS lymphoma + +/− +/−
  • Single mass with ring enhancement
  • B cell origin
  • Similar to non hodgkin lymphoma (diffuse large B cell)
  • Biopsy
  • Usually in young immunocompromized patients (HIV) or old immunocompetent person.
Childhood primary brain tumors Pilocytic astrocytoma + +/− +/−
  • Infratentorial
  • Solid and cystic component
  • Mostly in posterior fossa
  • Usually in cerebellar hemisphers and vermis
  • Glial cell origin
  • Solid and cystic component
  • GFAP +
  • Biopsy
  • Most of the time, cerebellar dysfunction is the presenting signs.
Medulloblastoma + +/− +/−
  • Infratentorial
  • Mostly in cerebellum
  • Non communicating hydrocephalus
  • Neuroectoderm origin
  • Homer wright rosettes
  • Biopsy
  • Drop metastasis ( metastasis through CSF)
Ependymoma + +/− +/−
  • Infratentorial
  • Usually found in 4th ventricle
  • Mixed cystic/solid lesion
  • Hydrocephalus
  • Ependymal cell origin
  • Perivascular pseudorosette
  • Biopsy
  • Causes an unusually persistent, continuous headache in children.
Craniopharyngioma + +/− + Bitemporal hemianopia
  • Hypopituitarism as a result of pressure effect on pituitary gland
  • Calcification
  • Lobulated contour
  • Motor-oil like fluid within tumor
  • Ectodermal origin (Rathkes pouch)
  • Calcification +
  • Biopsy
  • Initialy presents with lower bitemporal quadrantanopsia followed by bitemporal hemianopsia (pressure on optic chiasma from above)
Pinealoma + +/− +/− + vertical gaze palsy +
  • + B-hCG rise leads to precocious puberty in males
  • Hydrochepalus (compression of cerebral aqueduct)
  • Similar to testicular seminoma
  • Biopsy
Vascular AV malformation + +
  • Supratentorial: ~85%
  • Flow voids on T2 weighted images
  • We do not perform biopsy for AVM
  • Angiography
  • We may see bag of worms" appearance in CT angiography
Brain aneurysm +
  • In magnetic resonance angiography, we may see aneurysm mostly in anterior circulation (~85%)
  • We do not perform biopsy for brain aneurysm
  • Magnetic resonance angiography and CT angiography (Angiographjy is reserved for patients who have negative MRA and CTA)
  • It is associated with autosomal dominant polycystic kidney disease, Ehlers-Danlos syndrome, pseudoxanthoma elasticum and Bicuspid aortic valve.
Infectious Bacterial brain abscess + +
  • Leukocytosis
  • Elevated ESR
  • Blood culture may be positive for underlying organism
  • Central hypodense signal and surrounding ring-enhancement in T1
  • Central hyperintense area surrounded by a well-defined hypointense capsule with surrounding edema in T2
  • We do not perform biopsy for brain abscess
  • Clinical presentation/ imaging
Tuberculosis + +
  • Hydrocephalus combined with marked basilar meningeal enhancement
Toxoplasmosis +
  • Multifocal masses with ring enhancement
  • Mostly in basal ganglia, thalami, and corticomedullary junction.
Hydatid cyst +
Fungal +
Other Brain metastasis +
  • Multiple lesions
  • Vasogenic edema
  • Based on the primary cancer type we may have different immunohistopathology findings.
  • History/ imaging
  • If there is any uncertainty about etiology, biopsy should be performed
  • Most common primary tumors that metastasis to brain:
    • Lung cancer
    • Renal cell carcinoma
    • Breast cancer
    • Melanoma
    • Gastrointestinal tract

References

Template:WH Template:WS